Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
san francisco blog main
5
×
san francisco top stories
5
×
boston blog main
boston top stories
national top stories
new york blog main
startups
boulder/denver blog main
cancer
cancer diagnostics
drug development
freenome
grail
liquid biopsy
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco
thrive earlier detection
vc
23andme
abbvie
accent therapeutics
actavalon
acute myeloid leukemia
aducanumab
aileron therapeutics
alphabet
alzheimer's disease
amblyotech
american academy of ophthalmology
analytics
aprea therapeutics
arimoclomol
arnold levine
What
developing
5
×
company
new
based
blood
cancer
drugs
ipo
medicines
tests
activity
adds
aims
analyzes
announced
approach
approvals
area
bay
bio
biogen
biopsy
biotech
broader
buildout
called
ceo
clamped
close
covid
data
debuts
delays
detect
devices
economic
electronic
epigenetic
epigenetics
fast
Language
unset
Current search:
biotech
×
developing
×
" san francisco blog main "
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO